Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00207168
Status:
COMPLETED
Last Update Posted:
2011-04-22
First Post:
2005-09-12
Brief Title:
To Assess Compliance With a Once-daily Regimen of Lamivudine Efavirenz and Didanosine
Sponsor:
Organization:
Bristol-Myers Squibb